CBPO China Biologic Products Inc.
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
- 20.29 P/E
- 4.95 P/S
- 4.29 P/B
- 1.858 EPS
- 39.91% Cash ROIC
- 1.32 Cash Ratio
- 0 / 0% Dividend
- 23,647.00 Avg. Vol.
- 25.57M Shares
- 940.1M Market Cap.
China Biologic Products, Inc., a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and...
MarketWatch - Mar 4, 2014
PR Newswire (press release) - Mar 3, 2014
Wall Street Journal - 4 hours ago
FxPips.com - Feb 20, 2014
Wall Street Journal - 17 hours ago
Seeking Alpha - 7 hours ago
DC Bureau - Mar 10, 2014
Businessweek - 17 hours ago
PR Web (press release) - Mar 8, 2014
Richmond Times Dispatch - Mar 3, 2014